Wed, Jan 28, 2015, 2:14 PM EST - U.S. Markets close in 1 hr 46 mins


% | $
Quotes you view appear here for quick access.

Berkshire Hathaway Inc. Message Board

macrocosmonaut 19 posts  |  Last Activity: Oct 22, 2014 1:54 PM Member since: Aug 30, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • The company remainy heavily undervalued with sight on their assets and future potential. The CEO has already developed the Canon Mine at Breakwater Resources.

    Breakwater has been bougth by Nystar with around 230 million US-Dollar.

    The stock of Breakwater has climbed from 0.20 $ per share to around a peak high at 35 USD within four years.

    The same is possible to Mineral Hill Industries within the next years. The low cost mine is able to generate significant value to share holders in future.

    Do your own due dilligence.


    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Oct 22, 2014 1:47 PM Flag

    I am upgrading HEB from underperform to longterm outperform.

    This estimate on the basis of promising new development to combat viral diseases such as Ebola.

    Ebola is attacking human antiviral alpha-Interferon responce. The role of alpha interferon is crucial in order to combat Ebola infection.

    The Ro of Ebola Pandemic is between 1.7 and 2.2 - so one Ebola patient is infecting two new persons.

    This means that Ebola outbreak will spread around the planet within a few months. The USA has only 9 special beds fpr Ebola patients in the whole country at 4 hospitals in the whole country.

    This means - as soon as 9 patients has developed Ebola - the pandemic in the USA will run out of control and spread to million of people in the follow up.

    No vaccine will be available within the next 9-12 monts. I expect 2-5 million infeckions in the USA until spring.

    Alpha Interferon treatment will play an essential role to combat viral disease like Marburg, Ebola or other viral hemorraghis fever diseases.

    The Glycoprotein 40 (GP40) in combination with GP 1 and GP2 are inhibiting host antiviral response by alpha interferon. Adding Alpha interferon to infected Ebola patients is able to reduce the viral load and to increase survival rate in infected patients.

    Alpha Interferon play a crucial role in the innate immune response in first line immune response to viral agents like Ebola.

    So the Alpha Interferon therapy will lead to new therapeutic effects in Ebola diseases.

    Do your own due dilligence.


    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Sep 30, 2014 4:49 PM Flag

    The current marcet cap is reflecting a strong and irrational undervaluation at RBI Energy - similar to PLUG Power at 2013.

    The current marcet cap is extremly low and RB Energy is a possible take over target with sight on their assets.

    Tesla for example could buy the company easily in ordert to support the Gigafactory of its Lithium portfolio.

    Do your own due dilligence.


    Sentiment: Strong Buy

  • Reply to

    PSDV - upgrade - new PT 8 USD

    by macrocosmonaut Sep 29, 2014 5:10 PM
    macrocosmonaut macrocosmonaut Sep 29, 2014 8:46 PM Flag

    You want to know who I am ?

    So let´s start 6 years ago at the beginning of this thread. When PSDV started trading in the USA and I made the first recommendations at this stock - and was alone on this thread in a market hammered to the bottom.

    It was the time, when the financial crisis reached its climax and I predicted a big future within 2 years to this stock - and the stock climbed from 0.60 USD above 6 USD within 2 years and tenfold its value for the first time.

    Then the first morons came to this board - and I said its time to take the profits. And I sold my PSDV shares and realized the profits. I warned at that time even the Alimera shareholdes that PSDV and ALIM are able to drop to 1 USD in the follow up. And now try to find out waht the PPS of PSDV and ALIM did later after the first rally phase ?

    Correct - PSDV dropped to 1 USD and ALIM lost 90 percent of its value.

    Now I am recommending PSDV again an increasing the Price target from 1 USD to 8 USD. This estimate is based on several circumstances. Morons are shorting now this stock - and these morons will pay the profits to longterm investors. 8 USD is the minimum price target - the stock can even hit 21-35 USD within two years, if ALIM is able to treat around 40 000 patients globally in a year - each injection with propably 12500 USD per dose.

    Now try to make a good caluculation and PSDV is getting 20 percent...

    8 USD is possible in midterm future. Stock is moving in an intact long set up.

    Further - I want to point out, if you have no clue about sciences, technicals and medicine and ophthalmology you should better shut up and keep calm.


    Sentiment: Hold

  • macrocosmonaut by macrocosmonaut Sep 29, 2014 5:10 PM Flag

    I am upgrading PSDV after the approval by the FDA from sell, to hold and I am increasing the price tartget to 8 USD per share.

    This estimate is based on the new developments of the past days and the possibility that the Iluvien sales are able to reach 500 Million USD annual sales by Alimera., if around 40 000 patients a year are treated with Iluvien in a global context.

    If Psivida is getting 20 percent of the revenues, this means around 100 Million USD per year to Psivida. In such a case the stock is undervalued.

    Discounting some risk of the future I am increasing the Price target on midterm view from 1 USD to 8 USD.

    Do your own due dilligence.


    Sentiment: Hold

  • LEXG share price has dropped from around 11 USD to 0.009 USD per share.

    While the stock was heavily overvalued at around 11 USD - now this stock is heavily undervalued from my point of view.

    From technical point of view the stock should be able to climb to the 0.25 and 0.50 USD range per share in future.

    Current market cap isn´t reflecting the potential of the Lithium claims of LEXG.

    Even the water and oil projects are interesting projects of LEXG.

    This stock has a technical exaggeration at the downside. Take a look at the volume signals.


    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut Sep 18, 2014 12:15 PM Flag

    Thank you for the correction.

    Delisting process will start when the stock will below 1 USD within the next 30 days.

    However - tax selling and other effects like overvaluation as described yesterday are able to sent the stock price lower.

    I think yesterday was a so called decrease selling.

    The real sell of will come at aroun 0.13 USD from my point of view.

    I think this sell of will be combined with cash infusion and dilution and a reverse split.

    The company needs cash in order not to go bankrupt.


    Best regards.


    Sentiment: Sell

  • ONCY share price dropped today to new lows and generated new sell signals - non regarding short term bounce traders.

    The study results are disspointing and from my point of view the whole Reolysin technology is questionable.

    The company is burning millions of cash and has no commercial produkt. The equity is significant below current stock price and market cap.

    Delisting and a delisting notice is coming with high presumability within the next 10 days.

    If this will happen PPS per share will drop below 0.50 USD.

    Further the company has to raise cash in order to keep in good standing. If the company isn´t able to raise cash they will go bankrupt.

    So with sight in the high risk profile and current overvaluation I see a risk adjusted fair value at present at 0.13 USD per share.

    Do your own due dilligence and note - that if ONCY isn´t able to be NASDAQ compliant that only a reverse split is able to helb the company in order to avoid delisting.


    Sentiment: Sell

  • Today the stock has made a classical sell off on huge volume.

    The company is heavily undervalued at present and the bearish sentiment indicates that the price of the stock has bottomed today.

    In a longterm view and even near and midterm view the presumability is hight that the company will increase sharesholders value within the next years in significant manner.

    This stock is able to be a multibillion US Dollar stock within a fews years.

    Watch and learn.

    Shorting undervalued stocks at current levels is very risky.

    Chance/Risk proportion is favourable for long trades.

    Do your own due dilligence.


    Sentiment: Strong Buy

  • After a technical analysis of complex wave patterns I am recommending INTC as a strong sell.

    The first PT is 17 USD per share on midterm view. The Longterm PT is below 10 USD - at 4.xx USD per share.

    Do your own due dilligence.


    Sentiment: Strong Sell

  • macrocosmonaut macrocosmonaut Aug 22, 2014 6:10 PM Flag

    I bought more today. Thanks for the shares.


    Sentiment: Strong Buy

  • This stock is another overvalued biotech stock. The company is extremly overvalued and able to drop below 2 USD in future.

    Investors should take a look at the insider selling. Ebola has no businuess to BCRX and is of no relevance.

    If the Ebola hype is gone, the PPS of BCRX will decline sharply.

    Do your own due dilligence.


    Sentiment: Strong Sell

  • macrocosmonaut by macrocosmonaut Aug 19, 2014 2:06 PM Flag

    In a first estimate I am recommending TKMR as strong sell. The company is burning nearly 60 million US$ cash annually. So the company will run out of cash next year - and if the get no new financing - the company is able to go bankrupt.

    Current marcet cap is a joke - the stock is extremly overvalued and make no money.

    In this background I am recommending TKMR as underperformer and investors should be carefull with sight on the risks to the downside at this stock,

    The stock is able to drop like a stone.

    PT 0.50 USD per share.


    Sentiment: Strong Sell

  • macrocosmonaut macrocosmonaut Aug 9, 2014 1:42 PM Flag

    The shares of Silver Bull Resources (AMEX: SVBL and TSX: SCC) is to be taken worth a closer look. Not only because that the company has in Mexico over NI 43-101 compliant silver reserves and resources of 180 million ounces, but also under asset and technical aspects.

    The company is rated very attractive and is overlooking its silver deposits in the light of current market capitalization to look at and review aspects as a potential takeover target.

    Chart Technically, the formation of a 1-2-3 Lows draws from ...

    At strategic investors therefore not lagging behind. The insider buy for more than one year increased over the stock one. The range of insider purchases ranges from $ 0.26 per share to $ 0.43 per share.

    The stock was before the financial crisis still at around 5.70 USD in the high - but then in the context of the financial crisis in course sections in which they listed again today. Later shares of SVBL recover back up to the range of about 1:50 to 1.60 USD per share. The Make or Break Line for strategic positions should therefore be at 1.60 USD.

    Bias change at Silver Bull Resources?

    Possible short-term and medium-term growth scenario in SVBL ...

    Currently, only paid in the bottom of the Company's properties around 0.23 USD per ounce silver. Given the current production cost of silver and silver prices this is almost be described as dirt cheap - and basically been a joke.

    According to my own calculations and its own assessment - Risk Adjusted overlooking the Explorer stage of Silver Bull Resources under current market conditions and the likely expected production costs in the future - is a fair amount of 5 USD per ounce silver appropriate. For a transition to the stage of a silver producers, higher valuations appear quite justified. This is especially true when it comes to significant price increases for silver in the future..

    Do your own due dilligence.

    The intrinsic value per share is therefor

    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut Aug 6, 2014 6:07 PM Flag

    Double Bottom will be confirmed above 0.35 USD per share. Afterwards a first rally should start to the upside.

    The current wave 2 correction is a traders dream an just the beginning of longterm bullride at this stock to the described price targets.

    This company is debt free and has excellent assets.

    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut Aug 6, 2014 6:05 PM Flag

    Hi are you able to sent me the Symbol of the warrants you mentioned?

    Thanks in advance.

    Sentiment: Strong Buy

  • The stock is heavily overvalued at current stock price levels. The stock is valued more than 40-times of its equity and its burning cash.

    Obviously OHRP is the same company like Genaera - the same products and the same people.

    The trial results has in the endpoint data no significance with sight on the high P-values. Further I has no trust to the trial results, after Squalamine treatment in the trials of Genaera at 2007 has shown no significant effects or only marginal effects in the treatment of back of the eye diseases.

    So OHRP is even able to go bankrupt like Genaera a few years ago. The trials are very expensive and a statistical significant effect remains questionable.

    Additional risk are existing by the fact that many shareholdes has presumably bought this stock by margin.

    Even from technical point of view this stock is showing profit takting signals. Current measured bear move is indication a significant drop of stock price in future.

    Stock is able to become a penny stock within the next few years. Especially if the US Dollar will devaluate in significant manner.

    Price target 0.50 USD per share. If the trials fails the company will go bankrupt - like Genaera a few years ago.

    This stock is a high risk stock.


    Sentiment: Strong Sell

  • In a first estimate I recommend Silver Bull Resources as a longterm Sector Outperformer.

    The company is heavily undervalued with sight on its assets, debt free and able to 1000-fold its current market cap with sight on future fundamental developments.

    The value of 180 million ounces of Silver at the Assets of this company is reflecting a longterm sustainable asset of extremly high valuation.

    The stock will be one of the most wanted stock in the financial universe and when massmedia is detecting the value of this stock the stock will hit stock price levels of 280 USD and more per share.

    This scenario will be additionally supported by heavily increasing silver prices within the next 10 years up to 250 - 350 USD per ounce of silver.

    This price development of silver will be the first step of an ultimative Silver rally - which is able to lead to parabolic increasing silver prices and gold prices in future.

    Watch and learn. The stock is a historical buying opportunity at current stock price levels.


    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Jul 30, 2014 9:44 AM Flag

    The numbery are out and it seems to be that the businuess of PAL is improving.

    The longterm reversal situation is even improving from technical point of view.

    I am upgrading PAL from hold to strong buy with sight on the improved stockholders equity and the current results.


    Sentiment: Strong Buy

147.03-0.62(-0.42%)2:14 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.